Navigation Links
Cardiome Reports 2009 Results
Date:3/9/2010

legislation that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: we may not be able to successfully develop and obtain regulatory approval for vernakalant (iv) or vernakalant (oral) in the treatment of atrial fibrillation or any other current or future products in our targeted indications; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of
'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans
2. Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
3. Cardiome to Release Third Quarter Results
4. Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial
5. Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk
6. Cardiome Pharma Corp. Announces Final Results of Tender Offer
7. Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
8. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
9. Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
10. Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
11. Cardiome to Hold Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The Case Management Society of America ... CMSA Lifetime Achievement Award, to Anne Llewellyn RN-BC, MS, ... 25th at the association’s 25th Annual Conference and Expo ... The CMSA Board of Directors awards the Lifetime Achievement ... significant contribution to practice of case management and in ...
(Date:5/27/2015)... May 27, 2015 Water, ... water filtration products, has announced that its elite ... of the first to pass the new NSF/ANSI ... certification is monumental, proving that the BG-12000 by ... pharmaceuticals, over-the-counter medications, and chemicals used in manufacturing ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 One of ... an upcoming episode of “In America” that takes a ... condition is best described as an abnormal heart rhythm. ... that beats either irregularly or much too quickly. , ... atrial fibrillation develops in an effort to inform viewers ...
(Date:5/27/2015)... 2015 HomeTown Health, along with other ... Georgia cities on May 13 & 14. In each ... to meet with the group of representatives and receive ... office staff attended. , Referred to as the ... bring together Health Information Technology and ICD-10 resources with ...
(Date:5/26/2015)... May 27, 2015 In celebration of Parker ... is offering a discount on HVAC systems with a high ... , HVAC systems with a SEER rating around 15-16 ... as $20/month. For those unfamiliar with a SEER rating, it ... More specifically, it measures the amount of energy expended by ...
Breaking Medicine News(10 mins):Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3Health News:Parker and Sons Recounts its Path to Success 2
... in getting married and more involvements in serious family relationships ... male psychology. // ,About 12,000 men and women, ... regarding sex, living together, marriage, divorce and parenting by the ... first agency study involving men since 1973. ,Nearly ...
... of Virginia Commonwealth University Massey Cancer Center have discovered ... small molecules containing platinum, which causes HIV and cancer. ... the researchers to develop new drugs to fight HIV ... fingers. ,In the May 30 issue of ...
... summer, mosquitoes too are out to suck warm blood. Apart ... lethal injection of many harmful diseases//. ,The program-in-charge ... an ambient atmosphere for mosquito to breed. In his words,' ... the United States in human population density and we're in ...
... A new research has shown promising development for women in ... researchers state that for women over 35 years undergoing IVF ... their chances of conception. They also state that the rates ... cut down. ,The researchers from Finland found that ...
... study conducted by the researchers at the Hamburg Outstation ... Max Planck Institute for //Infection Biology (MPIIB) has found ... TB bacteria to survive which could be targeted by ... deadliest and the oldest disease. It is caused by ...
... general belief that every thing in the US of ... to a report by an independent environmental organisation Sierra ... Americans get unsafe drinking water. They attribute it to ... Act protections from headwater and seasonal streams. ...
Cached Medicine News:Health News:New Research May Be Useful for Developing Drugs for HIV and Cancer 2Health News:Research Shows That Quality Not Age As The Most Important Factor In IVF 2Health News:Drinking water in America not all that safe: says report 2
(Date:5/26/2015)... May 26, 2015  AbbVie (NYSE: ABBV ... GIFT-I study of its investigational, all-oral, interferon (IFN)- ... ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan ... . 1 GIFT-I evaluated genotype 1b ... patients, with and without cirrhosis, who were either ...
(Date:5/26/2015)... BRAINTREE, Mass. , May 26, 2015  Haemonetics ... Gerry Gould , Vice President, Investor Relations, will present ... Boston on June 4 th , ... public may access Mr. Gould,s presentation live via webcast ... Haemonetics (NYSE: HAE ) is a global ...
(Date:5/26/2015)... , May 26, 2015  XRpro Sciences, Inc., a ... services which features high throughput transporter and ion channel assays ... present at the 2015 Marcum MicroCap Conference on ... at the Grand Hyatt Hotel. The ... Timothy Tyson , Chairman is scheduled to begin at 1:30 ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6XRpro Sciences, Inc. To Present at 2015 Marcum MicroCap Conference 2
... human-animal hybrids to generate stem cells WORCESTER, Mass., ... Sheets: ACTC) and its collaborators reported today that human ... adult human cells. The research, which appears online ahead ... Cells (Editor-in-Chief: Sir Ian Wilmut; published by Mary ...
... Robert C. Gallo Foundation for AIDS and Virus ... as director of international relations. The foundation ... internationally known for expertise in HIV prevention, treatment ... producing groundbreaking HIV research."It is an honor to ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: